| Year |
Citation |
Score |
| 2016 |
Hauenstein JE, Liebenberg AP, Matthews BK, O'Hare CS, Thompson KS, Phillips CN, Williams JM, Vega JEV, Hunter SB, Brat DJ, Olson JJ, Schniederjan MJ, Neill SG, Rossi MR, Saxe DF. Toward Standardized Reporting and Databasing of Polyploid Tumors Cancer Genetics and Cytogenetics. 209: 289. DOI: 10.1016/J.Cancergen.2016.04.019 |
0.325 |
|
| 2012 |
Lee M, Hao C, Hunter S, Shu H, Petros J, Cohen C. Isocitrate Dehydrogenase 1 Expression in Prostate Carcinomas and Other Common Tumors American Journal of Clinical Pathology. 138. DOI: 10.1093/Ajcp/138.Suppl1.107 |
0.322 |
|
| 2011 |
Zhu D, Hunter SB, Vertino PM, Van Meir EG. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Research. 71: 5859-70. PMID 21724586 DOI: 10.1158/0008-5472.Can-11-1157 |
0.314 |
|
| 2004 |
Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. The International Journal of Biochemistry & Cell Biology. 36: 1046-69. PMID 15094120 DOI: 10.1016/J.Biocel.2004.01.013 |
0.31 |
|
| 2004 |
Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Research. 64: 920-7. PMID 14871821 DOI: 10.1158/0008-5472.Can-03-2073 |
0.315 |
|
| 2003 |
Hunter SB, Brat DJ, Olson JJ, Von Deimling A, Zhou W, Van Meir EG. Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). International Journal of Oncology. 23: 857-69. PMID 12963964 DOI: 10.3892/Ijo.23.4.857 |
0.35 |
|
| 2003 |
Hill C, Hunter SB, Brat DJ. Genetic markers in glioblastoma: prognostic significance and future therapeutic implications. Advances in Anatomic Pathology. 10: 212-7. PMID 12826827 DOI: 10.1097/00125480-200307000-00004 |
0.309 |
|
| 2002 |
Hunter SB, Moreno CS. Expression microarray analysis of brain tumors: what have we learned so far. Frontiers in Bioscience : a Journal and Virtual Library. 7: c74-82. PMID 12133823 DOI: 10.2741/A761 |
0.328 |
|
| 2002 |
Hunter S, Young A, Olson J, Brat DJ, Bowers G, Wilcox JN, Jaye D, Mendrinos S, Neish A. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. Journal of Neuropathology and Experimental Neurology. 61: 275-81. PMID 11895042 DOI: 10.1093/Jnen/61.3.275 |
0.328 |
|
| 2001 |
Schultz AB, Brat DJ, Oyesiku NM, Hunter SB. Intrasellar pituicytoma in a patient with other endocrine neoplasms. Archives of Pathology & Laboratory Medicine. 125: 527-30. PMID 11260629 DOI: 10.1043/0003-9985(2001)125<0527:Ipiapw>2.0.Co;2 |
0.345 |
|
| 1999 |
Alleyne CH, He J, Yang J, Hunter SB, Cotsonis G, James CD, Olson JJ. Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas. International Journal of Oncology. 14: 1111-6. PMID 10339666 DOI: 10.3892/Ijo.14.6.1111 |
0.31 |
|
| 1995 |
Barnett DW, Olson JJ, Thomas WG, Hunter SB. Low-grade astrocytomas arising from the pineal gland. Surgical Neurology. 43: 70-5; discussion 75-. PMID 7701429 DOI: 10.1016/0090-3019(95)80043-G |
0.336 |
|
| 1995 |
Olson JJ, James CD, Krisht A, Barnett D, Hunter S. Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors Neurosurgery. 36: 740-748. PMID 7596505 DOI: 10.1227/00006123-199504000-00015 |
0.338 |
|
| 1994 |
Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. American Journal of Surgery. 168: 373-80. PMID 7526718 DOI: 10.1016/S0002-9610(05)80079-0 |
0.314 |
|
| 1990 |
Hunter S, Hewan-Lowe K, Costa MJ. Primary pulmonary α-fetoprotein-producing malignant germ cell tumor Human Pathology. 21: 1074-1076. PMID 1698705 DOI: 10.1016/0046-8177(90)90259-8 |
0.352 |
|
| Show low-probability matches. |
